查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1461237

全球電生理學市場評估：依產品、適應症、最終用戶、地區、機會和預測（2017-2031）

Electrophysiology Market Assessment, By Product, By Indication, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 235 Pages | 商品交期: 3-5個工作天內

價格

全球電生理學市場規模預計將從2023年的89.2億美元增加至2031年的239.4億美元，2024-2031年預測期間複合年增長率為13.13%。市場成長受到多種因素的推動，例如全球人口心血管疾病盛行率的增加和老年人口的增加。技術進步和醫療器材產業的成長也是促使該市場成長的因素。此外，有利的監管制度的建立、多個主要參與者和新進入者的存在、聯合活動的增加以及新產品的頻繁發佈正在加速市場成長。

除此之外，全世界心血管疾病的盛行率不斷上升，特別是在不斷增加的老年人口中，也是一個促進生長的因素。由此，大眾對心房顫動、室上性心搏過速等心臟相關疾病的認識有所提高，進一步加速了電生理學在這些疾病治療中的應用。電生理學設備是獲取異常快速或慢心跳資訊的可靠工具。因此，公共和私人組織對投資這些設備表現出極大的興趣。該行業的技術進步以及公共和私人機構投資的增加正在促使全球市場需求的增加。

不斷增加的研發活動、有利的監管框架以及市場進入者頻繁推出的產品進一步推動了全球電生理學市場的發展。此外，FDA 對改善患者治療效果的創新產品的批准不斷增加，也支持了市場的成長。例如，醫療技術先驅Medtronic plc的兩款電生理設備已獲得 FDA 批准：Aurora EV-ICD MRI SureScan 和 Epsila EV MRI SureScan 除顫器。這些設備在治療可能導致心臟驟停的快速心跳方面非常有效，並且正在推出。此外，組織之間的併購、聯盟和分銷協議等穩定的合作活動正在進一步推動全球電生理學市場的發展。

心血管疾病盛行率增加

市場的快速成長可歸因於全球心血管疾病盛行率的增加。例如，根據《World Heart Report 2023》，2021年，心血管疾病影響了全球超過5億人，並導致2,050萬人死亡。隨著此類病例的增加，對電生理設備的需求也增加。這些設備在診斷、監測和控制異常心跳方面發揮關鍵作用，進一步降低了心臟衰竭和心臟驟停等致命健康狀況的可能性。此外，主要市場參與者不斷投資開發創新的先進電生理學解決方案，以滿足越來越多患有致命心臟病的人的需求，這推動了市場的成長。

技術進步

隨著對電生理治療的需求不斷增加，研發活動不斷增加，以向市場推出創新和先進的技術產品。整合遠端監控系統和人工智慧的使用等技術創新正在促進全球市場的擴張。例如，2023年9月，Kestra Medical Technologies宣佈推出ASSURE穿戴式心臟復律去顫器（WCD）系統，讓患者配戴簡單舒適。該系統使用遠端患者資料平台來幫助監測和保護有心臟驟停風險的患者。由於這些市場參與者的創新和有益的技術進步，全球電生理學市場預計將蓬勃發展。

電生理學市場對治療設備的需求不斷增加

從產品細分來看，電生理市場治療設備佔據主要佔有率，預計將持續維持全球電生理市場第一的地位。主要參與者頻繁推出產品和收緊法規正在加速電生理學市場的成長。因此，多個市場參與者始終將治療異常心跳的電生理設備納入其產品組合中。

本報告研究和分析了全球電生理學市場，提供市場規模和預測、市場動態、主要參與者現狀和前景等。

目錄

第一章研究方法論

第二章 專案範圍與定義

第三章執行摘要

第四章全球電生理學市場展望（2017-2031）

  • 市場規模及預測
    • 金錢金額
    • 數量
  • 依產品
    • 治療設備
    • 診斷設備
  • 依指示
    • 心房顫動 (AF)
    • 心室上性心搏過速
    • 房室結折返性心搏過速 (AVNRT)
    • 沃爾夫-帕金森-懷特症候群 (WPW)
    • 心動過緩
    • 其他
  • 依最終用戶
    • 醫院
    • 診斷中心
    • 其他
  • 依地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美洲
    • 中東/非洲
  • 市場佔有率：依公司劃分（2023 年）

第五章全球電生理學市場展望：依地區（2017-2031）

  • 北美
    • 市場規模及預測
    • 依產品
    • 依指示
    • 依最終用戶
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 俄羅斯
    • 荷蘭
    • 西班牙
    • 土耳其
    • 波蘭
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 澳大利亞
    • 越南
    • 韓國
    • 印度尼西亞
    • 菲律賓
  • 南美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合酋長國
    • 南非

第六章 市場測繪（2023）

  • 依產品
  • 依指示
  • 依最終用戶
  • 依地區

第七章 宏觀環境與產業結構

  • 供需分析
  • 進出口分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第八章市場動態

  • 增長動力
  • 成長限制因素（問題、限制因素）

第九章 監理架構與創新

  • 臨床試驗
  • 專利情況
  • 監管審批
  • 創新/新技術

第十章 主要公司情況

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 名市場領導者的市場收入分析（2023 年）
  • 併購/合資（如適用）
  • SWOT 分析（5 家市場公司）

第11章價格分析

第十二章案例研究

第十三章 主要公司展望

  • Biosense Webster Inc. (Johnson & Johnson)
  • Abbott Laboratories
  • GE HealthCare Technologies Inc.
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • Medtronic Inc.
  • MicroPort Scientific Corporation
  • Molecular Devices LLC
  • Siemens Healthcare GmbH
  • Stereotaxis Inc.

第十四章 戰略建議

第十五章 查詢及免責聲明

Product Code: MX11237

Global electrophysiology market is projected to witness a CAGR of 13.13% during the forecast period 2024-2031, growing from USD 8.92 billion in 2023 to USD 23.94 billion in 2031. Growth in the global electrophysiology market is driven by various factors, such as increasing prevalence of cardiovascular diseases among the global population and a rising geriatric population. Technological advancements and the growing medical devices industry are other factors leading to the growth of this market. Moreover, establishing a favorable regulatory system, the presence of several top players and new entrants, rising collaborative activities, and frequent new product launches are accelerating the market growth.

Apart from this, the increasing prevalence of cardiovascular diseases, especially among the rising geriatric population, across the globe is acting as another growth-inducing factor. This, in turn, has made people more conscious about heart-related ailments, such as atrial fibrillation and supraventricular tachycardia, further accelerating the application of electrophysiology for treating these diseases. Electrophysiology devices are highly reliable tools for information about abnormally fast or slow heart rhythms. Due to this, there is a huge interest of public and private organizations to invest in these devices. Technological advancements in the industry and increased investments by public and private organizations are leading to the increased demand for this market at the global level.

Increased research and development activities, favorable regulatory frameworks, and frequent product launches by market players further enhance the global electrophysiology market. Additionally, there has been increased FDA approvals for innovative products for improved patient outcomes, supporting market growth. For instance, Medtronic plc, a pioneer in healthcare technology, received FDA approval for two electrophysiology devices, Aurora EV-ICD MRI SureScan and Epsila EV MRI SureScan defibrillation. These devices are highly efficient and launched to treat dangerously fast heart rhythms, which can cause sudden cardiac arrest. Moreover, consistent collaboration activities, such as mergers and acquisitions, partnerships, and distribution agreements between the organizations, further propels the global electrophysiology market.

Increasing Prevalence of Cardiovascular Diseases

The surge in the global electrophysiology market can be attributed to the increasing prevalence of cardiovascular diseases worldwide. For instance, according to "World Heart Report 2023", in the year 2021, cardiovascular diseases affected over 500 million individuals globally, resulting in 20.5 million deaths, which represents nearly one-third of all global fatalities. As these cases increase, the demand for electrophysiology devices also increases. These devices play a crucial role in diagnosing, monitoring, and controlling abnormal heart rhythms that further reduces the chances of fatal health conditions such as heart failures and cardiac arrest. Moreover, key market players are consistently investing in developing innovative and advanced electrophysiology solutions to cater to the need of this growing population suffering from fatal heart conditions, which, in turn, is favoring the market growth.

Technological Advancements

With the growing demand for electrophysiology treatment options, there has been increased research and development activities in the market to introduce innovative and technologically advanced product variants. Innovations, such as integrated remote monitoring system and use of artificial intelligence (AI), are helping the market expand at the global level. For instance, in September 2023, Kestra Medical Technologies announced the launch of "ASSURE Wearable Cardioverter Defibrillator (WCD) system", which can be easily and comfortably worn by patients. This system uses a remote patient data platform that assists in monitoring and protecting patients at the risk of sudden cardiac arrest. Due to these innovative, beneficial technological advancements by the market players, the global electrophysiology market is expected to flourish.

Increased Demand for Treatment Devices in the Electrophysiology Market

Among the product segment, treatment devices in the electrophysiology market hold a significant share and are expected to maintain its leadership in the overall global electrophysiology market. Frequent product launches by the leading players, along with increased regulatory frameworks, lead to faster growth of the electrophysiology market. Due to this, several market players are consistently developing electrophysiology devices for treating abnormal heart rhythms in their product portfolio. For instance, in February 2023, Abbott launched two products that have recently received FDA approvals in the electrophysiology market. The first one is TactiFlex Ablation Catheter, which is sensor-enabled and the world's only CE-marked ablation catheter available with a flexible tip and contact force sensing, approved for treating abnormal heart rhythms such as atrial fibrillation. Abbott's another electrophysiology product "FlexAbility Ablation Catheter" has also received FDA approval for treating patients with complex heart conditions. These innovative product launches by leading players assist in propelling growth of the global electrophysiology market.

High Product Demand in Atrial Fibrillation

Among the indication segment, electrophysiology devices are widely used in atrial fibrillation condition, and it is anticipated that this segment will be the fastest growing segment in this market. As per GE Healthcare, atrial fibrillation is the most common arrhythmic condition that is majorly diagnosed worldwide. It is estimated that, by the year 2050, in the United States, 15.9 million people could be affected by atrial fibrillation and by the year 2060, 17.9 million people in Europe could be affected by this disease. As a result, the application of electrophysiological devices to treat atrial fibrillation is also increasing, leading to its huge demand in this segment. Several market players are developing innovative electrophysiology devices in their product portfolio to expand their market presence. For instance, GE HealthCare announced the launch of CardioVisio, especially for diagnosing and treating atrial fibrillation. This latest product is a digital tool that has been designed to assist clinicians in diagnosing and treating atrial fibrillation disease progression.

North America Holds Significant Market Share

The North American region holds the maximum share in the global electrophysiology market due to its robust healthcare infrastructure and facilities, availability of technologically advanced products, frequent innovative and advanced product launches, favorable regulatory frameworks, and the presence of key market players such as Biosense Webster Inc. and Boston Scientific Corporation. Moreover, the increased prevalence of cardiovascular diseases is also enhancing the growth of this market. For instance, according to Centers for Disease Control and Prevention, the most common cause of death in the United States is heart disease and it also states that over 805,000 Americans suffer a heart attack each year. Due to this, there is increased demand for electrophysiology products, which play a crucial role in providing accurate diagnosis and targeted treatment of heart rhythm disorders. Moreover, favorable regulatory frameworks and increased research and development further drive the growth of this market in North America.

Future Market Scenario (2024 - 2031F)

The global electrophysiology market is expected to grow in the future, primarily due to the increasing prevalence of heart-related health conditions, such as atrial fibrillation and Wolff-Parkinson-White Syndrome, that can lead to heart failure and strokes. Electrophysiology devices reduce the chances of these adverse health outcomes by providing detailed insights, detecting the areas responsible for abnormal heart rhythms, and assisting in potential treatment that further improves quality of life. Technological advancements and increased use of electrophysiology devices in the healthcare industry are other main factors leading to the growth of the global electrophysiology market. Frequent product launches, collaboration activities, and new entrants in this market are expected to flourish in the global electrophysiology market in the forecast period.

Key Players Landscape and Outlook

In the electrophysiology market, several medical device manufacturers are consistently establishing strategic partnerships, and undergoing distribution agreements, which play an essential role in propelling the global electrophysiology market's expansion. These partnerships enable companies to gain informative insights regarding the market trends, access each other's knowledge, resources, markets, and technologies, and invest in research and development activities to bring highly efficient and cost-effective electrophysiology products in the market. Distribution agreements enable companies to broaden their market presence at a global level. These collaborative ventures promote innovation, expedite product development, and contribute to the enduring and robust growth of the global market. For instance, in January 2023, Ra Medical Systems, Inc. announced the successful completion of its stock-for-stock merger transaction with Catheter Precision, Inc., which is a well-established company that works on developing cardiac electrophysiology market. This strategic collaboration will enable technological advancement in this industry as well as further assist in elevating the global electrophysiology market.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Electrophysiology Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
    • 4.1.2.By Volume
  • 4.2.By Product
    • 4.2.1.Treatment Devices
      • 4.2.1.1.Implantable Cardioverter Defibrillators (ICDs)
      • 4.2.1.2.Automated External Defibrillators (AEDs)
      • 4.2.1.3.Pacemakers
      • 4.2.1.4.CRT-P
      • 4.2.1.5.CRT-D
      • 4.2.1.6.Catheters
      • 4.2.1.7.Others
    • 4.2.2.Diagnostics Devices
      • 4.2.2.1.Holter Monitoring Devices
      • 4.2.2.2.Diagnostic Electrophysiology Catheters
      • 4.2.2.3.Electrocardiograph (ECG)
      • 4.2.2.4.EP Mapping & Imaging Systems
      • 4.2.2.5.Insertable Cardiac Monitors (ICM)
      • 4.2.2.6.Others
  • 4.3.By Indication
    • 4.3.1.Atrial Fibrillation (AF)
    • 4.3.2.Supraventricular Tachycardia
    • 4.3.3.Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
    • 4.3.4.Wolff-Parkinson-White Syndrome (WPW)
    • 4.3.5.Bradycardia
    • 4.3.6.Other
  • 4.4.By End-user
    • 4.4.1.Hospitals
    • 4.4.2.Diagnostic Centers
    • 4.4.3.Others
  • 4.5.By Region
    • 4.5.1.North America
    • 4.5.2.Europe
    • 4.5.3.Asia-Pacific
    • 4.5.4.South America
    • 4.5.5.Middle East and Africa
  • 4.6.By Company Market Share (%), 2023

5.Global Electrophysiology Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2.By Product
      • 5.1.2.1.Treatment Devices
      • 5.1.2.1.1.Implantable Cardioverter Defibrillators (ICDs)
      • 5.1.2.1.2.Automated External Defibrillators (AEDs)
      • 5.1.2.1.3.Pacemakers
      • 5.1.2.1.4.CRT-P
      • 5.1.2.1.5.CRT-D
      • 5.1.2.1.6.Catheters
      • 5.1.2.1.7.Others
      • 5.1.2.2.Diagnostics Devices
      • 5.1.2.2.1.Holter Monitoring Devices
      • 5.1.2.2.2.Diagnostic Electrophysiology Catheters
      • 5.1.2.2.3.Electrocardiograph (ECG)
      • 5.1.2.2.4.EP Mapping & Imaging Systems
      • 5.1.2.2.5.Insertable Cardiac Monitors (ICM)
      • 5.1.2.2.6.Others
    • 5.1.3.By Indication
      • 5.1.3.1.Atrial Fibrillation (AF)
      • 5.1.3.2.Supraventricular Tachycardia
      • 5.1.3.3.Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
      • 5.1.3.4.Wolff-Parkinson-White Syndrome (WPW)
      • 5.1.3.5.Bradycardia
      • 5.1.3.6.Other
    • 5.1.4.By End-user
      • 5.1.4.1.Hospitals
      • 5.1.4.2.Diagnostic Centers
      • 5.1.4.3.Others
    • 5.1.5.United States*
      • 5.1.5.1.Market Size & Forecast
      • 5.1.5.1.1.By Value
      • 5.1.5.1.2.By Volume
      • 5.1.5.2.By Product
      • 5.1.5.2.1.Treatment Devices
      • 5.1.5.2.1.1.Implantable Cardioverter Defibrillators (ICDs)
      • 5.1.5.2.1.2.Automated External Defibrillators (AEDs)
      • 5.1.5.2.1.3.Pacemakers
      • 5.1.5.2.1.4.CRT-P
      • 5.1.5.2.1.5.CRT-D
      • 5.1.5.2.1.6.Catheters
      • 5.1.5.2.1.7.Others
      • 5.1.5.2.2.Diagnostics Devices
      • 5.1.5.2.2.1.Holter Monitoring Devices
      • 5.1.5.2.2.2.Diagnostic Electrophysiology Catheters
      • 5.1.5.2.2.3.Electrocardiograph (ECG)
      • 5.1.5.2.2.4.EP Mapping & Imaging Systems
      • 5.1.5.2.2.5.Insertable Cardiac Monitors (ICM)
      • 5.1.5.2.2.6.Others
      • 5.1.5.3.By Indication
      • 5.1.5.3.1.Atrial Fibrillation (AF)
      • 5.1.5.3.2.Supraventricular Tachycardia
      • 5.1.5.3.3.Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
      • 5.1.5.3.4.Wolff-Parkinson-White Syndrome (WPW)
      • 5.1.5.3.5.Bradycardia
      • 5.1.5.3.6.Other
      • 5.1.5.4.By End-user
      • 5.1.5.4.1.Hospitals
      • 5.1.5.4.2.Diagnostic Centers
      • 5.1.5.4.3.Others
    • 5.1.6.Canada
    • 5.1.7.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East & Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Product
  • 6.2.By Indication
  • 6.3.By End-user
  • 6.4.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat from New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Clinical Trials
  • 9.2.Patent Landscape
  • 9.3.Regulatory Approvals
  • 9.4.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.Biosense Webster Inc. (Johnson & Johnson)
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products & Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus & Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Abbott Laboratories
  • 13.3.GE HealthCare Technologies Inc.
  • 13.4.Boston Scientific Corporation
  • 13.5.Koninklijke Philips N.V.
  • 13.6.Medtronic Inc.
  • 13.7.MicroPort Scientific Corporation
  • 13.8.Molecular Devices LLC
  • 13.9.Siemens Healthcare GmbH
  • 13.10.Stereotaxis Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 2.Global Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 3.Global Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 4.Global Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 5.Global Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 6.Global Electrophysiology Market Share (%), By Region, 2017-2031F
  • Figure 7.North America Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 8.North America Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 9.North America Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 10.North America Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 11.North America Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 12.North America Electrophysiology Market Share (%), By Country, 2017-2031F
  • Figure 13.United States Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 14.United States Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 15.United States Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 16.United States Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 17.United States Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 18.Canada Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 19.Canada Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 20.Canada Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 21.Canada Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 22.Canada Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 23.Mexico Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 24.Mexico Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 25.Mexico Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 26.Mexico Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 27.Mexico Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 28.Europe Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 29.Europe Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 30.Europe Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 31.Europe Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 32.Europe Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Electrophysiology Market Share (%), By Country, 2017-2031F
  • Figure 34.Germany Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 35.Germany Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 36.Germany Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 37.Germany Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 38.Germany Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 39.France Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 40.France Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 41.France Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 42.France Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 43.France Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 44.Italy Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 45.Italy Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 46.Italy Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 47.Italy Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 48.Italy Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 49.United Kingdom Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 50.United Kingdom Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 51.United Kingdom Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 52.United Kingdom Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 53.United Kingdom Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 54.Russia Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 55.Russia Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 56.Russia Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 57.Russia Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 58.Russia Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 59.Netherlands Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 60.Netherlands Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 61.Netherlands Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 62.Netherlands Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 63.Netherlands Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 64.Spain Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 65.Spain Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 66.Spain Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 67.Spain Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 68.Spain Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 69.Turkey Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 70.Turkey Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 71.Turkey Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 72.Turkey Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 73.Turkey Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 74.Poland Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 75.Poland Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 76.Poland Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 77.Poland Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 78.Poland Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 79.South America Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 80.South America Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 81.South America Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 82.South America Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 83.South America Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 84.South America Electrophysiology Market Share (%), By Country, 2017-2031F
  • Figure 85.Brazil Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 86.Brazil Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 87.Brazil Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 88.Brazil Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 89.Brazil Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 90.Argentina Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 91.Argentina Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 92.Argentina Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 93.Argentina Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 94.Argentina Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 95.Asia-Pacific Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 96.Asia-Pacific Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 97.Asia-Pacific Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 98.Asia-Pacific Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 99.Asia-Pacific Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 100.Asia-Pacific Electrophysiology Market Share (%), By Country, 2017-2031F
  • Figure 101.India Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 102.India Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 103.India Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 104.India Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 105.India Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 106.China Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 107.China Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 108.China Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 109.China Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 110.China Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 111.Japan Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 112.Japan Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 113.Japan Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 114.Japan Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 115.Japan Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 116.Australia Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 117.Australia Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 118.Australia Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 119.Australia Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 120.Australia Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 121.Vietnam Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 122.Vietnam Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 123.Vietnam Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 124.Vietnam Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 125.Vietnam Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 126.South Korea Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 127.South Korea Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 128.South Korea Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 129.South Korea Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 130.South Korea Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 131.Indonesia Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 132.Indonesia Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 133.Indonesia Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 134.Indonesia Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 135.Indonesia Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 136.Philippines Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 137.Philippines Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 138.Philippines Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 139.Philippines Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 140.Philippines Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 141.Middle East & Africa Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 142.Middle East & Africa Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 143.Middle East & Africa Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 144.Middle East & Africa Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 145.Middle East & Africa Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 146.Middle East & Africa Electrophysiology Market Share (%), By Country, 2017-2031F
  • Figure 147.Saudi Arabia Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 148.Saudi Arabia Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 149.Saudi Arabia Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 150.Saudi Arabia Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 151.Saudi Arabia Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 152.UAE Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 153.UAE Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 154.UAE Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 155.UAE Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 156.UAE Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 157.South Africa Electrophysiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 158.South Africa Electrophysiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 159.South Africa Electrophysiology Market Share (%), By Product, 2017-2031F
  • Figure 160.South Africa Electrophysiology Market Share (%), By Indication, 2017-2031F
  • Figure 161.South Africa Electrophysiology Market Share (%), By End-user, 2017-2031F
  • Figure 162.By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163.By Indication Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023